UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent warming by latitude associated with increased length of ragweed pollen season in central North America

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (10), p.4248-4251

2011

Volltextzugriff (PDF)

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

The New England journal of medicine, 2021-10, Vol.385 (18), p.1656-1668

2021

Volltextzugriff (PDF)

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

The lancet respiratory medicine, 2022-01, Vol.10 (1), p.11-25

2022

Volltextzugriff (PDF)

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

Advances in therapy, 2018-05, Vol.35 (5), p.737-748

2018

Volltextzugriff (PDF)

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

Annals of allergy, asthma, & immunology, 2020-11, Vol.125 (5), p.565-576.e1

2020

Volltextzugriff (PDF)

Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma

The European respiratory journal, 2021-10, Vol.58 (4), p.2004498

2021

Volltextzugriff (PDF)

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2020-02, Vol.8 (2), p.527-539.e9

2020

Volltextzugriff (PDF)

Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history

Annals of allergy, asthma, & immunology, 2019-08, Vol.123 (2), p.222-224.e1

2019

Volltextzugriff (PDF)

Joint association between ambient air pollutant mixture and pediatric asthma exacerbations

Environmental epidemiology, 2022-10, Vol.6 (5), p.e225

2022

Volltextzugriff (PDF)

Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-07, Vol.10 (7), p.1835-1843

2022

Volltextzugriff (PDF)

Extraordinary Alternaria Mold Counts During a Severe Drought

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB16-AB16

2014

Volltextzugriff (PDF)

A comparison of fluticasone propionate nasal spray and cetirizine in ragweed fall seasonal allergic rhinitis

Allergy and asthma proceedings, 2015-07, Vol.36 (4), p.313-319

2015

Volltextzugriff (PDF)

Patient satisfaction with beclomethasone dipropionate nasal aerosol device with integrated dose counter during daily use

Allergy and asthma proceedings, 2013-11, Vol.34 (6), p.527-533

2013

Volltextzugriff (PDF)

Cannabis (hemp) positive skin tests and respiratory symptoms

Annals of allergy, asthma, & immunology, 2000-09, Vol.85 (3), p.238-240

2000

Volltextzugriff (PDF)

Dupilumab Suppresses Type 2 Biomarkers in Asthma Patients With and Without Comorbid Chronic Rhinosinusitis With or Without Nasal Polyposis (CRS/NP): Post Hoc Analysis of LIBERTY ASTHMA QUEST

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB98-AB98

2019

Volltextzugriff (PDF)

Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB97-AB97

2019

Volltextzugriff (PDF)

Dupilumab Suppresses Inflammatory Biomarkers in Asthma Patients With or Without Allergic Rhinitis: Post Hoc Analysis of the LIBERTY ASTHMA QUEST Study

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB97-AB97

2019

Volltextzugriff (PDF)

Efficacy and safety of fluticasone propionate 250 μg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids

Annals of allergy, asthma, & immunology, 2002-10, Vol.89 (4), p.393-399

2002

Volltextzugriff (PDF)

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

Journal of Clinical Immunology, 2006-07, Vol.26 (4), p.388-395

2006

Volltextzugriff (PDF)

The heart and soul of the American Medical Association

Medscape general medicine, 2006-07, Vol.8 (3), p.5

Ford, Linda B

2006

Volltextzugriff (PDF)

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma

Journal of allergy and clinical immunology, 1999-06, Vol.103 (6), p.1062-1068

1999

Volltextzugriff (PDF)

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma

Journal of allergy and clinical immunology, 1997-10, Vol.100 (4), p.467-474

1997

Volltextzugriff (PDF)

Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids

Annals of allergy, asthma, & immunology, 2002-10, Vol.89 (4), p.393

2002

Volltextzugriff (PDF)

Ask the expert

Asthma (Newton, Mass.), 1999-05, Vol.4 (3), p.23

Ford, Linda B.

1999

Volltextzugriff (PDF)

Ask the expert

Asthma (Newton, Mass.), 1999, Vol.4 (3), p.23-23

Ford, Linda B.

1999

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(147)

Publikationsform

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(123)
Humans
(108)
Female
(77)
Male
(65)
Middle Aged
(55)
Aged
(49)
Biological And Medical Sciences
(47)
Medical Sciences
(41)
Adult
(38)
Risk Factors
(30)
General & Internal Medicine
(27)
Adolescent
(26)
Medicine, General & Internal
(26)
Double-Blind Method
(21)
Treatment Outcome
(18)
United States
(18)
Child
(17)
Cardiovascular System & Cardiology
(16)
Public, Environmental & Occupational Health
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recent warming by latitude associated with increased length of ragweed pollen season in central North America

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis

Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history

Joint association between ambient air pollutant mixture and pediatric asthma exacerbations

Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose

Extraordinary Alternaria Mold Counts During a Severe Drought

A comparison of fluticasone propionate nasal spray and cetirizine in ragweed fall seasonal allergic rhinitis

Patient satisfaction with beclomethasone dipropionate nasal aerosol device with integrated dose counter during daily use

Cannabis (hemp) positive skin tests and respiratory symptoms

Dupilumab Suppresses Type 2 Biomarkers in Asthma Patients With and Without Comorbid Chronic Rhinosinusitis With or Without Nasal Polyposis (CRS/NP): Post Hoc Analysis of LIBERTY ASTHMA QUEST

Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study

Dupilumab Suppresses Inflammatory Biomarkers in Asthma Patients With or Without Allergic Rhinitis: Post Hoc Analysis of the LIBERTY ASTHMA QUEST Study

Efficacy and safety of fluticasone propionate 250 μg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

The heart and soul of the American Medical Association

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma

Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids

Ask the expert

Ask the expert

Aktive Filter

Suchergebnisse filtern